Banque Pictet & Cie’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,805
| Closed | -$837K | – | 615 |
|
|
2022
Q3 | $837K | Sell |
12,805
-45
| -0.4% | -$2.94K | 0.01% | 422 |
|
|
2022
Q2 | $781 | Sell |
12,850
-82,578
| -87% | -$5.02K | 0.01% | 468 |
|
|
2022
Q1 | $5.99M | Buy |
95,428
+626
| +0.7% | +$39.3K | 0.05% | 175 |
|
|
2021
Q4 | $7.18M | Buy |
94,802
+83,783
| +760% | +$6.35M | 0.05% | 173 |
|
|
2021
Q3 | $1.23M | Buy |
11,019
+1,238
| +13% | +$139K | 0.01% | 241 |
|
|
2021
Q2 | $1.58M | Buy |
9,781
+2,994
| +44% | +$485K | 0.02% | 221 |
|
|
2021
Q1 | $827K | Buy |
6,787
+5,414
| +394% | +$660K | 0.01% | 265 |
|
|
2020
Q4 | $210K | Buy |
+1,373
| New | +$210K | ﹤0.01% | 315 |
|